1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Particulate Matter Exposure and Allergic Rhinitis: The Role of Plasmatic Extracellular Vesicles and Bacterial Nasal Microbiome.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Particulate matter (PM) exposure is linked to the worsening of respiratory conditions, including allergic rhinitis (AR), as it can trigger nasal and systemic inflammation. To unveil the underlying molecular mechanisms, we investigated the effects of PM exposure on the release of plasmatic extracellular vesicles (EV) and on the complex cross-talk between the host and the nasal microbiome. To this aim, we evaluated the effects of PM10 and PM2.5 exposures on both the bacteria-derived-EV portion (bEV) and the host-derived EVs (hEV), as well as on bacterial nasal microbiome (bNM) features in 26 AR patients and 24 matched healthy subjects (HS). In addition, we assessed the role exerted by the bNM as a modifier of PM effects on the complex EV signaling network in the paradigmatic context of AR. We observed that PM exposure differently affected EV release and bNM composition in HS compared to AR, thus potentially contributing to the molecular mechanisms underlying AR. The obtained results represent the first step towards the understanding of the complex signaling network linking external stimuli, bNM composition, and the immune risponse.

          Related collections

          Author and article information

          Journal
          Int J Environ Res Public Health
          International journal of environmental research and public health
          MDPI AG
          1660-4601
          1660-4601
          Oct 12 2021
          : 18
          : 20
          Affiliations
          [1 ] EPIGET LAB, Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
          [2 ] Department of Preventive Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
          [3 ] GlaxoSmithKline Consumer Healthcare, Warren, NJ 07059, USA.
          [4 ] GlaxoSmithKline Consumer Healthcare, CH-1260 Nyon, Switzerland.
          [5 ] GlaxoSmithKline Consumer Healthcare, Weybridge KT13 0DE, UK.
          Article
          ijerph182010689
          10.3390/ijerph182010689
          8535327
          34682436
          af5151fd-8c3c-4a92-96a6-1331a054db5f
          History

          particulate matter exposure,allergic rhinitis,bacterial nasal microbiome,extracellular vesicles

          Comments

          Comment on this article